{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:18:38Z","timestamp":1776111518630,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00393-016-0249-1","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T09:41:52Z","timestamp":1484127712000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evidenzbasierte Empfehlung zur Diagnostik und Therapie der Gichtarthritis im fach\u00e4rztlichen Sektor","Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector"],"prefix":"10.1007","volume":"76","author":[{"given":"U.","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Alten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Manger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"N\u00fcsslein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reuss-Borst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schwarting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schulze-Koops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Tausche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"Suppl 2","key":"249_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00393-016-0147-6","volume":"75","author":"U Kiltz","year":"2016","unstructured":"Kiltz U, Alten R, Fleck M, Kruger K, Manger B, Muller-Ladner U et al (2016) Full version of the S2e guidelines on gouty arthritis: Evidence-based guidelines of the German Society of Rheumatology (DGRh). Z Rheumatol 75(Suppl 2):11\u201360","journal-title":"Z Rheumatol"},{"issue":"9711","key":"249_CR2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T (2010) Gout. Lancet 375(9711):318\u2013328","journal-title":"Lancet"},{"issue":"3","key":"249_CR3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00393-011-0953-9","volume":"71","author":"AK Tausche","year":"2012","unstructured":"Tausche AK, Manger B, Muller-Ladner U, Schmidt B (2012) Gout as a\u00a0systemic disease. Manifestations, complications and comorbidities of hyperuricaemia. Z Rheumatol 71(3):224\u2013230","journal-title":"Z Rheumatol"},{"issue":"5","key":"249_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T (2011) Clinical practice. Gout. N Engl J Med 364(5):443\u2013452","journal-title":"N Engl J Med"},{"issue":"2","key":"249_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/BOR.0b013e328343e458","volume":"23","author":"E Pascual","year":"2011","unstructured":"Pascual E, Sivera F, Andres M (2011) Synovial fluid analysis for crystals. Curr Opin Rheumatol 23(2):161\u2013169","journal-title":"Curr Opin Rheumatol"},{"issue":"13","key":"249_CR6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","volume":"170","author":"HJ Janssens","year":"2010","unstructured":"Janssens HJ, Fransen J, van de Lisdonk EH, van Riel PL, van Weel C, Janssen M (2010) A\u00a0diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med 170(13):1120\u20131126","journal-title":"Arch Intern Med"},{"issue":"10","key":"249_CR7","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D et\u00a0al (2015) 2015 gout classification criteria: An American College of Rheumatology\/European League Against Rheumatism Collaborative initiative. Arthritis Rheumatol 67(10):2557\u20132568","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"249_CR8","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2014-205431","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Taylor WJ, Weatherall M, Fransen J, Jansen TL, Neogi T et al (2015) Imaging modalities for the classification of gout: systematic literature review and meta-analysis. Ann Rheum Dis 74(10):1868\u20131874","journal-title":"Ann Rheum Dis"},{"key":"249_CR9","first-page":"CD010120","volume":"9","author":"CM Durme van","year":"2014","unstructured":"van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewe RB (2014) Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev 9:CD010120","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"249_CR10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW (2010) High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62(4):1060\u20131068","journal-title":"Arthritis Rheum"},{"key":"249_CR11","doi-asserted-by":"crossref","unstructured":"Richette P et al (2017) Updated Eular evidence-based recommendations for gout. Ann Rheum Dis 76:29\u201342","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"249_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707","author":"P Richette","year":"2016","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J et al (2016) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"249_CR13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","volume":"125","author":"TH Taylor","year":"2012","unstructured":"Taylor TH, Mecchella JN, Larson RJ, Kerin KD, Mackenzie TA (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a\u00a0randomized clinical trial. Am J Med 125(11):1126\u20131134.e7","journal-title":"Am J Med"},{"issue":"3","key":"249_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"A Shoji","year":"2004","unstructured":"Shoji A, Yamanaka H, Kamatani N (2004) A\u00a0retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51(3):321\u2013325","journal-title":"Arthritis Rheum"},{"issue":"8","key":"249_CR15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","volume":"66","author":"E Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Ann Rheum Dis 66(8):1056\u20131058","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"249_CR16","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et\u00a0al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64(10):1447\u20131461","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"23","key":"249_CR17","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr., Wortmann RL, MacDonald PA, Eustace D, Palo WA et\u00a0al (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353(23):2450\u20132461","journal-title":"N Engl J Med"},{"issue":"7","key":"249_CR18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med 125(7):679\u2013687.e1","journal-title":"Am J Med"},{"issue":"7","key":"249_CR19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et\u00a0al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis 67(7):960\u2013966","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"249_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437\u2013443","journal-title":"Pharmacotherapy"},{"issue":"2","key":"249_CR21","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA et al (2009) Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 11(2):R46","journal-title":"Arthritis Res Ther"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0249-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T07:38:54Z","timestamp":1658389134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0249-1"}},"subtitle":["S2e-Leitlinie der Deutschen Gesellschaft f\u00fcr Rheumatologie (DGRh) in Kooperation mit der AWMF","S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF"],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0249-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}